Technology-Assisted Early Mobilization Program Among Patients in the Intensive Care Units
Launched by HSIAO-YEAN CHIU · Nov 19, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different methods of early movement can help patients who are critically ill and may develop weakness from being in the intensive care unit (ICU). Researchers want to see if using technology to assist in movement, along with family support, is more effective than standard movement practices or just regular care. They will be enrolling 138 patients who are 18 years or older, have been on a ventilator for at least 24 hours, and are expected to stay in the ICU for more than four days. Participants will be divided into three groups: one will receive technology-assisted movement, another will get systematic movement without technology, and the last group will receive routine care.
Participants in the trial can expect to take part in activities aimed at improving their muscle strength, sleep, and overall well-being while in the ICU and after they leave. The study will track their progress at various points, including during their ICU stay and six months after they leave the hospital. It’s important to know that some people, such as those with certain medical conditions or severe muscle weakness, may not be eligible to join the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged ≥ 18 years
- • Being mechanically ventilated ≥ 24 hours
- • Richmond Agitation-Sedation Scale (RASS): 0 to -1
- • No vision, hearing, or body movements restriction
- • With clear consciousness and ability to communicate in Chinese
- • Expected to stay in the ICU \> 96 hours.
- Exclusion Criteria:
- • Being pregnant, menopausal, or having a night shift within one month before admission to the ICU
- • Have developed delirium before enrollment (ICDSC \> 4)
- • With acute physiology and chronic health evaluation (APACHE II) score \> 25 after ICU admission within 24 hours
- • With muscle weakness caused by severe acute brain injury (e.g., traumatic brain injury or stroke), spinal coral injury, other neuromuscular conduction diseases, or long-term bedridden or hemiplegia.
About Hsiao Yean Chiu
Hsiao-Yean Chiu is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic interventions. With a strong commitment to scientific rigor and ethical standards, the organization collaborates with leading research institutions and healthcare professionals to design, implement, and oversee clinical trials across various therapeutic areas. By leveraging cutting-edge methodologies and fostering a culture of transparency and collaboration, Hsiao-Yean Chiu aims to contribute significantly to the development of safe and effective treatments, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported